BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

«Lafora Disease

Below is an extended Lafora Disease research listing. Click here to return to the Lafora Disease main in depth entry.

Recent Publications on Lafora Disease:

Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin.
Lafora disease (LD) is a fatal form of teenage-onset autosomal recessive...
Direct Link
17th July, 2008
Department of Biological Sciences and Bioengineering, Indian Institute of
Modulation of functional properties of laforin phosphatase by alternative splicing reveals a novel mechanism for the EPM2A gene in Lafora progressive myoclonus epilepsy.
The EPM2A gene, encoding the dual-phosphatase laforin, is mutated in a...
Direct Link
12th July, 2008
Department of Biological Sciences and Bioengineering, Indian Institute of
[Subcutaneous midazolam infusion and Lafora disease] 4th July, 2008
The maestro don Gonzalo Rodriguez-Lafora.
Gonzalo Rodriguez-Lafora (1886-1971) was an influential Spanish...
Direct Link
26th June, 2008
Department of Neurological Surgery, University of California, Irvine,
Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG).
Lafora disease (LD) is an autosomal recessive neurodegenerative disease...
Direct Link
6th May, 2008
Department of Pharmacology, University of California at San Diego, La
Typical progression of myoclonic epilepsy of the Lafora type: a case report.
BACKGROUND: A 20-year-old woman presented to a specialist epilepsy center...
Direct Link
9th April, 2008
Division of Neurology, The Hospital for Sick Children, 555 University
Lafora progressive myoclonus epilepsy: disease course homogeneity in a genetic isolate.
Lafora epilepsy is characterized by starch formation in brain and skin and...
Direct Link
26th March, 2008
Program in Genetics and Genome Biology, The Hospital for Sick Children,
Lafora disease, seizures and sugars. 7th February, 2008
Division of Neurology, Krembil Neuroscience Centre, University of Toronto,
Mechanism suppressing glycogen synthesis in neurons and its demise in progressive myoclonus epilepsy.
Glycogen synthesis is normally absent in neurons. However, inclusion...
Direct Link
2nd February, 2008
Institute for Research in Biomedicine and University of Barcelona,
Laforin is a glycogen phosphatase, deficiency of which leads to elevated phosphorylation of glycogen in vivo.
Lafora disease is a progressive myoclonus epilepsy with onset typically in...
Direct Link
19th January, 2008
Department of Biochemistry and Molecular Biology, Indiana University
[Lafora's disease presenting with progressive myoclonus epilepsy]
Lafora's disease is a progressive myoclonus epilepsy and must be evocated...
Direct Link
17th January, 2008
Service
Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.
Inborn errors of metabolism (IEMs) represent poorly known causes of...
Direct Link
9th January, 2008
Federation of Nervous System Diseases, Reference Center for Lysosomal
A 12-year-old girl with seizures and dementia.
We report 2 cases of ground-glass hepatocyte inclusions occurring in...
Direct Link
22nd December, 2007
Lafora-like ground-glass inclusions in hepatocytes of pediatric patients: a report of two cases.
We report 2 cases of ground-glass hepatocyte inclusions occurring in...
Direct Link
13th December, 2007
Department of Pathology and Laboratory Medicine, The Mount Sinai Hospital,
Lafora disease: spectroscopy study correlated with neuropsychological findings.
PURPOSE: To evaluate the metabolic changes both in grey and white matter...
Direct Link
8th December, 2007
Neuroradiology Department, Neurological Institute IRCCS Fondazione
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional